ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

LUXEMBOURG / ACCESSWIRE / February 3, 2020 / Jean Boulle Medtech Ltd. (the "Company"), founder of Tendyne Holdings, Inc. ("Tendyne") and a Jean Boulle Group (the "Group") company developing medical ...

Boise, Idaho-based Saint Alphonsus Regional Medical Center became the first in the state to perform a Tendyne mitral valve replacement, the Daily Fly reported Dec. 7. The device is inserted through a ...

Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...

Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne") a privately held clinical stage ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...

SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...

ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option As the most common heart disease affecting the heart valves, MR ...